hábit Labs · Devolve Corp

Certificate of Analysis

Lot CJC-2607-AReleased Jul 202606 · Anabo
FOR RESEARCH PURPOSES ONLY. This material is supplied for in-vitro laboratory research by qualified researchers. It shall not be used for human therapeutic purposes and is not for human or veterinary consumption. It is not a drug, supplement, cosmetic, food additive, or medical device.

Product identification

ProductCJC-1295 (no DAC) 20mg
DescriptionGHRH analog · Mod GRF (1-29)
Lot numberCJC-2607-A
Release dateJul 2026
Molecular formulaC₁₅₂H₂₅₂N₄₄O₄₂
AppearanceLyophilized powder
Storage−20 °C, protected from light
ManufacturerDevolve Corp d/b/a hábit · Ft. Lauderdale, FL

Analytical results

Identity (LC-MS)Confirmed✓ Pass
Purity (HPLC)99.1%✓ Pass
Mass spec (MW)≈3,367.9✓ Pass
Endotoxin (LAL)<0.5 EU/mg✓ Pass
AppearanceWhite cake✓ Pass

LC-MS identity, HPLC purity (≥99%), mass spec confirmation against ≈3,367.9 g/mol, endotoxin by LAL, appearance. Third-party ISO-17025 verified.

Specifications

CAS863288-34-0
Molecular formulaC₁₅₂H₂₅₂N₄₄O₄₂
Molecular weight≈3,367.9 g/mol
FormLyophilized
Purity≥99% by HPLC
Endotoxin<0.5 EU/mg
Available dosages20mg
Lot prefixCJC-

Storage & handling

Lyophilized: −20°C, 24 months. Reconstituted: 2–8°C, use within 30 days. Reconstitute with bacteriostatic water; swirl gently, do not shake. Protect from repeated freeze-thaw.

Certificate metadata
Lot
CJC-2607-A
Released
Jul 2026
Tested by
Janus Analytical (ISO-17025)
Method
RP-HPLC · LC-MS · LAL · KF

Results relate only to the lot tested. Retain this certificate with your batch records. For the raw HPLC and mass-spec traces behind any assay, contact sales@myhabitlabs.com citing the lot number.

View product →